C100 AB (C100) Fair Value & Analysis
Technology · SE · Market cap 22.7M SEK
Fair value as of: Aug 2, 2026
From 1 valuation models · updated today
Share price +6.2% over the past month.
Below-average quality, and the price sits another 42% above our fair value.
What matters now
- The price sits above even our optimistic bull case (kr 3.58). The favourable scenario is already priced in.
- Weak quality (14/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- A fairly wide model range (kr 1.79 to kr 3.58) leaves room in how you read the outcome.
Price vs Fair Value (4 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 2, 2026.
How to read this chart
50‑month range kr 3.02 – kr 351.17 · fair‑value band kr 1.79 – kr 3.58 · the kr 4.12 price screens above the kr 2.40 fair value. Dashed = 300-day average. As of Aug 2, 2026.
Analysis
C100 AB (C100) currently trades at kr 4.12, while our model-based Fair Value estimate is kr 2.40, implying the stock looks roughly 41.8% overvalued today. We read business quality at 14/100 (below-average quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
It earns a return on equity of -35.0%. Fundamentals as of Aug 2, 2026
Our scenario range runs from kr 1.79 (bear case) to kr 3.58 (bull case); at kr 4.12, the current price sits above that range. The share trades about 74% below its 52-week high and 46% above its 52-week low, currently below its 200-day average. For context, the median of 10 Technology peers we cover trades at -25% fair-value upside, at -42%, C100 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 1 models by family
Key figures & financial health
Figures from reported company fundamentals · as of Aug 2, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 21 · Market factors (momentum, volatility) 22
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
C100 AB (publ) is public investment firm specializing in early stage, growth stage and emerging stage. The firm prefers to invest in technology and life science sector. It typically focuses on early-stage biotech platforms, emerging digital health technologies, transformative software solutions for the investments.
Full company description
C100 AB (publ) is public investment firm specializing in early stage, growth stage and emerging stage. The firm prefers to invest in technology and life science sector. It typically focuses on early-stage biotech platforms, emerging digital health technologies, transformative software solutions for the investments. C100 AB (publ) was founded in 2025 and is headquartered in Stockholm, Sweden.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
C100 AB reported revenue of kr 207K in FY2025 versus kr 843K in FY2022, a compound −37.4%/yr. Reported net income was −kr 3.2M in FY2025.
C100 sits 42% above fair value. Compare with International Business Machines Corporation →
Peer Group
Information Technology Services · 514 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Information Technology Services median · lower = cheaper
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Information Technology Services stocks, each showing price versus our Fair Value estimate (as of Aug 2, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| International Business Machines Corporation IBM | $211.20 | $146.77 | -31% |
| Accenture plc ACNN | 2,460 MXN | 250.95 MXN | -90% |
| Infosys Limited INFY | ₹1,156 | ₹1,457 | +26% |
| HCL Technologies Limited HCLTECH | ₹1,204 | ₹1,230 | +2% |
| Wipro Limited WIPRO | ₹178.43 | ₹226.81 | +27% |
| Tech Mahindra Limited TECHM | ₹1,455 | ₹1,086 | -25% |
| Samsung SDS Co 018260 | 199,300 KRW | 196,390 KRW | -1% |
| Persistent Systems Limited PERSISTENT | ₹5,059 | ₹2,364 | -53% |
| Hyundai Autoever Corporation 307950 | 393,000 KRW | 133,088 KRW | -66% |
| Coforge Limited COFORGE | ₹1,541 | ₹702.84 | -54% |
Compare C100 AB with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is C100 AB (C100) overvalued or undervalued?
What is the fair value of C100?
What is the quality score of C100?
What is the net profit margin of C100?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track C100 AB and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.